Gene Therapy Ready Site Network
Advarra knows gene therapy. Our growing network of Gene Therapy Ready sites are pre-registered, vetted, and standing by to conduct your clinical trial.
Leverage the world’s largest integrated IRB and IBC service combined with the most comprehensive Gene Therapy Ready site network to move your clinical trials forward—faster.
Gene Therapy Ready Sites:
Receive complimentary registration with NIH to have Advarra serve as your IBC of record
Demonstrate expertise and readiness to conduct your trials involving genetically engineered therapies and vaccines
Complete study start-up 5-6 weeks faster than non-GTR sites and 8-12 weeks faster than sites who use a local IBC
Request a Complete List of Gene Therapy Ready Sites
Is Your Site Ready?
Research into gene therapy-based treatments and mRNA based vaccines is accelerating exponentially. Is your research site ready to take advantage of this growing area of clinical trials?
Become Gene Therapy Ready by having Advarra registered as your IBC!